GDIGlobal Derivatives IntelligencePublished snapshotPRINT VIEW

EXECUTIVE BRIEF · 7 OCTOBER 2026

CME sets JIBAR conversion rehearsal; JSCC activates Phase 15.

Two operational changes missed in the prior scan enter the register with their original source dates and unresolved readiness evidence.

RESEARCH CUT-OFF 7 OCT · 06:50 CEST2material changes
Published content frozen

HISTORICAL CATCH-UP · Sources are dated 30 September and 4 October. CME’s rehearsal occurs after this cut-off; no successful test is inferred. JSCC confirmed its go-live decision, not the release scope or first-day outcome.

EXECUTIVE TAKEAWAYS

  1. 01RELATES TO · JIBAR CONVERSION ↓

    Rates / clearing / operations · Reconcile in-scope trades, replacement ZARONIA bookings and compensation cash in UAT, then retain the 28 October contingency path.

  2. 02RELATES TO · JSCC PHASE 15 ↓

    APAC OTC / technology · Obtain the Phase 15 change pack and reconcile participant messages, reports and exceptions before treating the release as operationally closed.

Action radar

NEWLY INDEXED · WATCH01

Operations · INT-2026-063 · 58/100 · SOURCE 2026-09-30

CME schedules JIBAR-to-ZARONIA rehearsal before November conversion

FACT · CME’s 30 September advisory schedules a UAT dress rehearsal for 7 October at 18:00 ET, ahead of the primary conversion of cleared three-month ZAR-JIBAR swaps on 20 November. The rehearsal covers contracts with fixings beyond the 31 December cessation date.

Why it matters

GDI ANALYSIS · Conversion, replacement bookings and cash compensation create a reconciled position-and-payment control event; a scheduled test is not evidence that participants or production are ready.

Likely business impact

Rates / clearing / operations · Reconcile in-scope trades, replacement ZARONIA bookings and compensation cash in UAT, then retain the 28 October contingency path.

What to watch

  • 7 October UAT results and unresolved position or payment breaks
  • 20 November production conversion; 4 December contingency date
  • LCH’s separate 10 October rehearsal and 21 November conversion
NEWLY INDEXED · WATCH02

Technology · INT-2026-064 · 47/100 · SOURCE 2026-10-04

JSCC activates Phase 15 of its OTC derivatives clearing system

FACT · JSCC said on 4 October that its Phase 15 OTC derivatives clearing-system update received go-live approval and would enter production on 5 October as scheduled.

Why it matters

GDI ANALYSIS · The production decision is confirmed, but the public notice does not disclose the functional scope, participant changes or first-day operating evidence; those gaps limit any broader readiness claim.

Likely business impact

APAC OTC / technology · Obtain the Phase 15 change pack and reconcile participant messages, reports and exceptions before treating the release as operationally closed.

What to watch

  • Phase 15 functional and interface scope
  • Participant acknowledgements, breaks and fallback evidence
  • First production-day outcome beyond JSCC’s go-live decision

Urgent open matters